Sandrine Brette
About
Sandrine Brette is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Economics and Econometrics.
According to data from OpenAlex, Sandrine Brette has authored 23 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 5 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Economics and Econometrics. Recurrent topics in Sandrine Brette's work include Cardiac Arrhythmias and Treatments (7 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Diabetes Management and Research (5 papers). Sandrine Brette is often cited by papers focused on Cardiac Arrhythmias and Treatments (7 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Diabetes Management and Research (5 papers). Sandrine Brette collaborates with scholars based in France, Germany and United Kingdom. Sandrine Brette's co-authors include Philippe Gabríel Steg, Lisa Naditch‐Brûlé, Habib Gamra, Chern‐En Chiang, Ján Murín, O. Zharinov, José Silva‐Cardoso, Piotr Ponikowski, Thorsten Lewalter and Marnix Goethals and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Neurology.
In The Last Decade
Sandrine Brette
22 papers receiving 337 citations
Peers
Sandrine Brette
Vincent A. Pallazola United States
Brian Jefferson United States
Matej Mlinarič Slovenia
Juniali Hatwal India
С. Б. Фитилев Russia
Niki Procopi France
Valeria Manfreda Italy
Émilie Pelletier-Beaumont Canada
Jocelyn J. Drinkwater Australia
Alessandra Schiavo Italy
Citations per year, relative to Sandrine Brette Sandrine Brette (= 1×)
peers
Vincent A. Pallazola
Countries citing papers authored by Sandrine Brette
Since
Specialization
Citations
This map shows the geographic impact of Sandrine Brette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandrine Brette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandrine Brette more than expected).
Fields of papers citing papers by Sandrine Brette
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Sandrine Brette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandrine Brette. The network helps show where Sandrine Brette may publish in the future.
Co-authorship network of co-authors of Sandrine Brette
This figure shows the co-authorship network connecting the top 25 collaborators of Sandrine Brette. A scholar is included among the top collaborators of Sandrine Brette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandrine Brette. Sandrine Brette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Taksande, Amar, et al.. (2022). Efficacy and safety of Bacillus clausii (O/C, N/R, SIN, T) probiotic combined with oral rehydration therapy (ORT) and zinc in acute diarrhea in children: a randomized, double-blind, placebo-controlled study in India. Tropical Diseases Travel Medicine and Vaccines. 8(1). 9–9.
2.
Wilmot, Emma G., Francisco Javier Ampudia‐Blasco, Lori Berard, et al.. (2020). 1629-P: Association of Patient-Reported Outcomes (PROs) Scores with Glycemic Target Achievement in Type 1 Diabetes (T1D) in the SAGE Study. Diabetes. 69(Supplement_1).
3.
Lakha, Deepak, et al.. (2019). A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Ambroxol Hard-Boiled Lozenges in Patients with Acute Pharyngitis. Pulmonary Therapy. 5(2). 201–211.
4.
Wiendl, Heinz, Catharina C. Groß, Melanie Eschborn, et al.. (2017). Teri-DYNAMIC: Exploring the impact of teriflunomide on immune cell population size, receptor repertoire, and function in patients with RRMS. Document Server@UHasselt (UHasselt).
5.
Coyle, Patricia K., Bhupendra Khatri, Keith R. Edwards, et al.. (2017). Patient-reported outcomes in relapsing forms of MS: Real-world, global treatment experience with teriflunomide from the Teri-PRO study. Multiple Sclerosis and Related Disorders. 17. 107–115.
6.
Blonde, Lawrence, Michel Marre, Sandrine Brette, et al.. (2017). Insulin regimens and glycemic control in different parts of Europe over 4 years after starting insulin in people with type 2 diabetes: Data from the CREDIT non-interventional study. Diabetes Research and Clinical Practice. 133. 150–158.
7.
Chiang, Chern‐En, Lisa Naditch‐Brûlé, Sandrine Brette, et al.. (2016). Atrial Fibrillation Management Strategies in Routine Clinical Practice: Insights from the International RealiseAF Survey. PLoS ONE. 11(1). e0147536–e0147536.
8.
Wiendl, Heinz, Catharina C. Groß, Maren Lindner, et al.. (2016). TERI-DYNAMIC: Exploring the Impact of Teriflunomide on Immune Cell Population Size, Receptor Repertoire, and Function in Patients With RRMS (P5.282). Neurology. 86(16_supplement).
9.
Darrat, Yousef, Jignesh Shah, Claude S. Elayi, et al.. (2016). Regional Lack of Consistency in the Management of Atrial Fibrillation (from the RECORD-AF Trial). The American Journal of Cardiology. 119(1). 47–51.
10.
Home, Philip, Marie‐Paule Dain, Nick Freemantle, et al.. (2015). Four-year evolution of insulin regimens, glycaemic control, hypoglycaemia and body weight after starting insulin therapy in type 2 diabetes across three continents. Diabetes Research and Clinical Practice. 108(2). 350–359.
11.
Wiendl, Heinz, Catharina C. Groß, Maren Lindner, et al.. (2015). Characterizing the impact of teriflunomide on adaptive immune cell subsets, repertoire and function in patients with relapsing-remitting MS: TERI-DYNAMIC. Document Server@UHasselt (UHasselt).
12.
Gamra, Habib, Ján Murín, Chern‐En Chiang, et al.. (2014). Use of antithrombotics in atrial fibrillation in Africa, Europe, Asia and South America: Insights from the International RealiseAF Survey. Archives of cardiovascular diseases. 107(2). 77–87.
13.
Taı̈eb, Julien, Roberto Bordonaro, Katia Bencardino, et al.. (2014). Quality of Life (Qol) on the Aflibercept/Folfiri Regimen: 4Th Interim Analysis of the Global Aflibercept Safety and Health-Related Qol Program. Annals of Oncology. 25. iv180–iv180.
14.
Taı̈eb, Julien, Roberto Bordonaro, Salvatore Siena, et al.. (2014). Quality of life maintained on the ziv-aflibercept/FOLFIRI regimen: Third interim analysis of the global aflibercept safety and HR-QOL program.. Journal of Clinical Oncology. 32(15_suppl). e14560–e14560.
15.
Murín, Ján, Lisa Naditch‐Brûlé, Sandrine Brette, et al.. (2014). Clinical Characteristics, Management, and Control of Permanent vs. Nonpermanent Atrial Fibrillation: Insights from the RealiseAF Survey. PLoS ONE. 9(1). e86443–e86443.
16.
Ferry, David, Alberto F. Sobrero, Roberto Bordonaro, et al.. (2014). Ziv-aflibercept (Z) in combination with FOLFIRI for second-line treatment of patients (pts) with metastatic colorectal cancer (mCRC): Interim safety data from the global aflibercept safety and quality-of-life program in pts pretreated with bevacizumab (B).. Journal of Clinical Oncology. 32(3_suppl). 556–556.
17.
Goethals, Marnix, James O’Neill, Lisa Naditch‐Brûlé, et al.. (2013). Inappropriate use of antiarrhythmic drugs in paroxysmal and persistent atrial fibrillation in a large contemporary international survey: insights from RealiseAF. EP Europace. 15(12). 1733–1740.
18.
Silva‐Cardoso, José, O. Zharinov, Piotr Ponikowski, et al.. (2013). Heart Failure in Patients With Atrial Fibrillation Is Associated With a High Symptom and Hospitalization Burden: The RealiseAF Survey. Clinical Cardiology. 36(12). 766–774.
19.
Steg, Philippe Gabríel, Samir Alam, Chern‐En Chiang, et al.. (2012). 225 Symptoms, functional status, and quality of life in patients with controlled and uncontrolled atrial fibrillation. Data from the cross-sectional REALISE-AF registry. Archives of Cardiovascular Diseases Supplements. 4(1). 71–72.
20.
Steg, Philippe Gabríel, Samir Alam, Chern‐En Chiang, et al.. (2011). Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: data from the RealiseAF cross-sectional international registry. Heart. 98(3). 195–201.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Vincent A. Pallazola Breakdown of academic impact, for papers by Brian Jefferson Breakdown of academic impact, for papers by Matej Mlinarič Breakdown of academic impact, for papers by Juniali Hatwal Breakdown of academic impact, for papers by С. Б. Фитилев Breakdown of academic impact, for papers by Niki Procopi Breakdown of academic impact, for papers by Valeria Manfreda Breakdown of academic impact, for papers by Émilie Pelletier-Beaumont Breakdown of academic impact, for papers by Jocelyn J. Drinkwater Breakdown of academic impact, for papers by Alessandra Schiavo